Gilead, Abbvie, Express Scripts, And Biotech Industry Turmoil Seen By Market-Makers
Peter F. Way, CFA - Seeking Alpha - Wed Dec 24, 8:33AM CST
This is a market price forecast analysis It is not an analysis of medical technology, competition, or economics. We have limited competence in those areas. But we do have extensive experience in how market professionals have interpreted the likely...
ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), FBT: 100.93 (+1.47), BIB: 122.51 (+3.83), XBI: 182.62 (+3.44), IBB: 299.80 (+5.12), BBH: 113.91 (+1.89), ABBV: 66.21 (+1.86)
Why I Expect The Biotech Sell-Off To Continue Into 2015
Sammy Pollack - at Seeking Alpha - Wed Dec 24, 7:08AM CST
BIIB: 340.89 (+5.13), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), IBB: 299.80 (+5.12), AMGN: 160.67 (+3.15), REGN: 400.12 (+6.07), CELG: 109.60 (+3.48)
Cramer's Mad Money - Navigator Holdings Has Been Unfairly Punished (12/23/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Wed Dec 24, 4:37AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday December 23. Navigator Holdings (NYSE: NVGS ) Has Been Unfairly Punished . Other stock mentioned: Transocean (NYSE: RIG ) With the surge in stocks, it...
RH: 96.97 (-0.16), GD: 141.54 (+0.23), LMT: 196.43 (+0.66), HON: 101.96 (-0.02), RTN: 110.47 (+0.29), NOC: 151.76 (+0.44), KMB: 117.77 (-0.21), XOM: 93.78 (-0.81), IBB: 299.80 (+5.12), VSAT: 63.75 (-0.20), NVGS: 20.00 (+2.10), JACK: 78.82 (-0.17), RIG: 18.77 (-0.37), Q: 59.48 (+0.01), COST: 143.65 (-0.50), WAG: 76.67 (+0.16), ETN: 69.30 (-0.09), MDSO: 47.27 (+0.15), DIS: 94.42 (-0.27), WFC: 55.34 (-0.13), PLKI: 55.50 (+0.01), BA: 131.24 (+1.21), DENN: 9.96 (+0.05), CBRL: 138.16 (+0.46), GILD: 91.29 (+1.84), CVX: 113.47 (-0.48)
Jim Cramer's 'Mad Money' Recap: Here Are 10 Stocks to Buy on Strong GDP Data
at The Street - Tue Dec 23, 7:26PM CST
Kimberly-Clark, Walgreen and Starbucks are among Cramer's winners on today's GDP number.
RH: 96.97 (-0.16), EYES: 11.01 (+0.86), ETN: 69.30 (-0.09), HON: 101.96 (-0.02), KMB: 117.77 (-0.21), IBB: 299.80 (+5.12), BMY: 59.15 (-0.01), PLKI: 55.50 (+0.01), MAR: 78.35 (-0.19), BA: 131.24 (+1.21), RRC: 55.73 (-1.27), VSAT: 63.75 (-0.20), SBUX: 81.27 (-0.16), NVGS: 20.00 (+2.10), COG: 30.21 (-0.39), GILD: 91.29 (+1.84), GWPH: 68.08 (+1.82), STI: 42.43 (-0.18), COST: 143.65 (-0.50), AI: 27.70 (-0.12), WAG: 76.67 (+0.16), PSEC: 8.59 (-0.02), EPD: 35.45 (+0.25)
Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Rebound after Yesterday's 4.65% Sell Off
Comtex SmarTrend(R) - Tue Dec 23, 3:40PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $292.04 to a high of $309.94. Yesterday, the shares fell 4.7%, which took the trading range below the 3-day low of $306.37 on volume of 3.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 299.80 (+5.12)
SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 4.65% Loss
Comtex SmarTrend(R) - Tue Dec 23, 3:39PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $292.04 to a high of $309.94. Yesterday, the shares fell 4.7%, which took the trading range below the 3-day low of $306.37 on volume of 3.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 299.80 (+5.12)
Investors Should Stay Long Stocks as Market Continues Hitting Highs
at The Street - Tue Dec 23, 2:01PM CST
The CNBC 'Fast Money Halftime' trading panel knows there could be some risks in 2015.
AMZN: 303.03 (-3.26), IBB: 299.80 (+5.12), ALSN: 33.94 (+0.05), BAC: 17.98 (+0.05), TLT: 123.95 (+0.41), GOOG: 528.77 (-1.82), ESRX: 85.48 (-0.40), SPY: 207.77 (+0.02), QQQ: 104.30 (+0.09), GILD: 91.29 (+1.84), DIA: 180.03 (unch), APA: 64.05 (-1.38), ABBV: 66.21 (+1.86), BP: 38.95 (-0.17), GOOGL: 536.93 (-1.84), IWM: 119.76 (-0.10), XLE: 80.13 (-0.59)
Inside The 2 New Innovative Biotech ETFs From BioShares
Zacks Funds - Seeking Alpha - Tue Dec 23, 2:00PM CST
The biotechnology corner of the broader health care industry has been one of the best performing U.S. sectors this year despite some temporary glitches and rough trading in between. Encouraging industry trends, increasing merger and acquisition...
BBP: 25.60 (+0.38), BBC: 26.85 (+0.48), FBT: 100.93 (+1.47), XBI: 182.62 (+3.44), IBB: 299.80 (+5.12)
Fed's Patience Puts Bulls In A Hurry
Scott Martindale - Seeking Alpha - Tue Dec 23, 11:08AM CST
U.S. stocks found support once again last week and rallied on strong volume. Of course, the main catalyst was the FOMC policy statement on Wednesday that maintained its dovish language with a pledge of considerable time before raising the fed funds...
DEF: 38.15 (-0.96), NFO: 49.34 (-0.38), PNW: 69.59 (+1.41), UTHR: 130.22 (+2.40), ED: 66.91 (+0.90), IBB: 299.80 (+5.12), LUV: 41.66 (+0.68), IYZ: 29.52 (-0.18), LYB: 81.31 (-0.89), SPY: 207.77 (+0.02), IDU: 120.07 (+1.13), IYW: 106.52 (-0.41), IYK: 106.07 (-0.66), IYJ: 108.21 (-0.61), IYH: 144.69 (+0.58), BCR: 169.10 (-0.44), IYM: 83.15 (-0.74), IYC: 137.57 (-0.15), NXPI: 76.75 (+0.48), FUTY: 31.00 (+0.60), IYF: 91.09 (-0.41), IYE: 45.37 (-0.54), PYZ: 53.07 (+0.10), SHW: 264.55 (+1.46), KNOW: 69.79 (+0.15)
Gilead Falls on AbbVie and Express Scripts Deal: 3 Biotech ETFs to Watch - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 11:02AM CST
Gilead shares fell more than 10 percent in Monday trading following news that AbbVie and Express Scripts signed an exclusive Hepatitis C.
PBE: 49.81 (+0.69), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), IBB: 299.80 (+5.12), BBH: 113.91 (+1.89), ABBV: 66.21 (+1.86)
Money flowing out of biotech today
Seeking Alpha - at Seeking Alpha - Tue Dec 23, 9:40AM CST
BIS: 47.26 (-1.74), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), BIB: 122.51 (+3.83), IBB: 299.80 (+5.12), ABBV: 66.21 (+1.86)
Inside the Two New Innovative Biotech ETFs from BioShares - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 7:02AM CST
Two interesting ETFs hit the market from BioShares targeting Clinical Trials and Biotechnology Products.
BBP: 25.60 (+0.38), BBC: 26.85 (+0.48), FBT: 100.93 (+1.47), XBI: 182.62 (+3.44), IBB: 299.80 (+5.12)
AbbVie Versus Gilead In Hepatitis C, With Comments On Biotech
DoctoRx - Seeking Alpha - Mon Dec 22, 1:09PM CST
Background : I have written more than once about a comparison of the entrants from Gilead Sciences (NASDAQ: GILD ) and AbbVie (NYSE: ABBV ) for hepatitis C. Now that AbbVie's Viekira Pak has been approved for marketing by the FDA (before the close...
ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), IBB: 299.80 (+5.12), ABBV: 66.21 (+1.86)
No Bargains in Rising Market: Why Not Buy High and Sell Higher?
at The Street - Mon Dec 22, 11:29AM CST
It is a rare and risky strategy, though some funds are proving it can be hugely rewarding.
MMTM: 88.10 (unch), MTUM: 68.74 (-0.14), IBB: 299.80 (+5.12), FXH: 60.73 (+0.42)
3 Drugmakers Facing a Pivotal 2015
George Budwell, The Motley Fool - Motley Fool - Mon Dec 22, 10:41AM CST
Source: www.bio.org Pharmaceutical companies have been some of the best performing stocks lately due to the confluence of an aging U.S. population and new regulatory avenues within the Food and Drug Administration that have led to an uptick in drug...
BIIB: 340.89 (+5.13), ISIS: 59.49 (+1.88), GWPH: 68.08 (+1.82), AZN: 70.44 (+0.26), IBB: 299.80 (+5.12), PTCT: 51.66 (+0.76), GSK: 42.85 (+0.11)
Bioshares New Equal Weight ETFs Offer Diversification And Growth
Chris Katje - at Seeking Alpha - Mon Dec 22, 10:01AM CST
BBP: 25.60 (+0.38), BBC: 26.85 (+0.48), IBB: 299.80 (+5.12), FXH: 60.73 (+0.42), XLV: 68.64 (+0.50)
GW Pharmaceuticals Added to NASDAQ Biotechnology Index
GlobeNewswire - Mon Dec 22, 1:00AM CST
GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (Nasdaq:NBI), which will become effective at the open of U.S. markets today.
GWPH: 68.08 (+1.82), IBB: 299.80 (+5.12)
The Markets Will Sink In Titanic Fashion
Papa of Four - at Seeking Alpha - Sat Dec 20, 8:08PM CST
USO: 21.05 (-0.51), F: 15.30 (-0.03), SPY: 207.77 (+0.02), QQQ: 104.30 (+0.09), GCI: 31.68 (-0.20), GLD: 112.77 (+0.03), DIA: 180.03 (unch), SNE: 21.32 (+0.46), IBB: 299.80 (+5.12), GM: 33.43 (-0.13)